Literature DB >> 5820716

[The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].

E Gründig, F Gerstenbrand, J Bruck, H Gnad, P Prosenz, R Teuflmayr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5820716

Source DB:  PubMed          Journal:  Dtsch Z Nervenheilkd        ISSN： 0367-004X


× No keyword cloud information.
  24 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  [EXPERIENCES WITH L-DOPA IN THE THERAPY OF PARKINSONISM].

Authors:  F GERSTENBRAND; K PATEISKY; P PROSENZ
Journal:  Psychiatr Neurol (Basel)       Date:  1963

3.  BIOCHEMICAL STUDIES IN HUNTINGTON'S CHOREA: ERYTHROCYTE MAGNESIUM.

Authors:  G W BRUYN; C J MINK; J F CALJE
Journal:  Neurology       Date:  1965-05       Impact factor: 9.910

4.  [On the effects of I-DOPA on motor disorders in Parkinson's syndrome. An electromyographic study].

Authors:  G GERSTENBRAND; K PATEISKY
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1962

5.  On the distribution in brain of monoamines and of enzymes responsible for their formation.

Authors:  A BERTLER; E ROSENGREN
Journal:  Experientia       Date:  1959-10-15

6.  Distribution of catechol compounds in human brain.

Authors:  I SANO; T GAMO; Y KAKIMOTO; K TANIGUCHI; M TAKESADA; K NISHINUMA
Journal:  Biochim Biophys Acta       Date:  1959-04

7.  A kinetic study of bovine adrenal tyrosine hydroxylase.

Authors:  M Ikeda; L A Fahien; S Udenfriend
Journal:  J Biol Chem       Date:  1966-10-10       Impact factor: 5.157

8.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  [Comparative biochemical studies in organic parkinsonian syndromes and drug induced parkinsonian syndromes].

Authors:  H Bruck; F Gerstenbrand; H Gnad; E Gründig; P Prosenz
Journal:  Psychiatr Neurol (Basel)       Date:  1966
View more
  5 in total

1.  [Biochemical aspects of the effect of L-dopa in patients with Parkinson's disease].

Authors:  E Gründig; F Gerstenbrand; J Oberhummer; M Simanyi; R Schedl; J Weiss
Journal:  Z Neurol       Date:  1972

2.  Cerebrospinal fluid amino acids in extrapyramidal disorders before and after L-DOPA treatment.

Authors:  M Van Sande; J Caers; A Lowenthal
Journal:  Z Neurol       Date:  1971-04-28

3.  [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].

Authors:  E Gründig; F Gerstenbrand; J Bruck; H Gnad; P Prosenz; M Simanyi
Journal:  Dtsch Z Nervenheilkd       Date:  1969

4.  [Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA].

Authors:  M Simanyi; F Gerstenbrand; E Gründig; R Schedl; H Weiss
Journal:  Z Neurol       Date:  1973-03-16

Review 5.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.